PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25929155-12 2015 CONCLUSION: These data show that d-Ala(8) GLP-1(Lys(37) ) pentasaccharide exerts significant antidiabetic actions and has a projected pharmacokinetic/pharmacodynamic profile that merits further evaluation in humans for a possible once-weekly dosing regimen. pentasaccharide 58-73 glucagon like peptide 1 receptor Homo sapiens 42-47